[Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia]. 1997

J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario, Universidad de Valencia.

Changes in insulin secretion were investigated in a group of non obese subjects with combined familial hyperlipidemia (CFH), with normal glucose tolerance, relating the observed changes with plasma triglycerides and lipoprotein phenotype. METHODS The study was conducted with 21 subjects (16 males and 5 females; mean age: 45.9 +/- 9.1 years), diagnosed of CFH after the clinical and analytical study of patients and their first degree relatives (9 with phenotype IIa, 8 IIb, and 4 IV) and 21 healthy control subjects, of similar age, sex and body weight. In both groups, lipids, plasma lipoproteins, glucose, basal plasma insulin, and insulin after and oral glucose overload (OGO) were quantitated. RESULTS Diastolic blood pressure was higher (p < 0.01) in CFH group compared with controls (means: 132/80 vs 123/71 mmHg, respectively). TC, TG and Apo B were also higher in the CFH group. With OGO significantly higher serum insulin levels were observed at 0, 30, 60, 90 and 120 minutes in CFH subjects compared with control group. Basal serum insulin and the area under the curve of insulin secretion after OGO was higher in subjects with triglycerides (45,579 +/- 13,056 in controls, 61,385 +/- 22,254 in CFH IIa, 70,645 +/- 17,271 IIb and 124,884 +/- 36,944 in CFH IV. Insulin secretion correlated significantly (p < 0.01) with plasma triglycerides. As conclusion, hyperinsulinism is a finding in CFH non obese subjects and with normal glucose tolerance, and has an increasing frequency in subjects with high triglycerides levels.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015228 Hypertriglyceridemia A condition of elevated levels of TRIGLYCERIDES in the blood. Hypertriglyceridemias

Related Publications

J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
February 1983, Journal of lipid research,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
September 2010, Journal of physiology and biochemistry,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
December 2001, Arteriosclerosis, thrombosis, and vascular biology,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
December 1985, Medicina clinica,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
August 1977, Annals of internal medicine,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
November 2008, Vnitrni lekarstvi,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
May 2005, Arteriosclerosis, thrombosis, and vascular biology,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
August 2008, Atherosclerosis,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
December 2000, Metabolism: clinical and experimental,
J F Ascaso, and J Sales, and A Merchante, and J T Real, and R I Lorente, and J Martínez-Valls, and R Carmena
December 2014, Circulation. Cardiovascular genetics,
Copied contents to your clipboard!